Resources

Draft – General Guidance for Prescribing

General Guidance Document for Prescribing, Dosing, and Titration of Medicinal Cannabis for Health Care Professionals (HCPs)

TGA resources

• Medicinal cannabis
• Access pathways
• SAS B portal registration
• SAS B guidance

TGA guidance Summary of evidence for medicinal cannabis

• Medicinal cannabis products: Patient information
• Guidance for the use of medicinal cannabis in Australia: Patient information
• Guidance for the use of medicinal cannabis in Australia: Overview
• Guidance for the use of medicinal cannabis in the treatment of multiple sclerosis in Australia
• Guidance for the use of medicinal cannabis in the treatment of palliative care patients in Australia
• Guidance for the use of medicinal cannabis in the treatment of epilepsy in paediatric and young adult patients in Australia
• Guidance for the use of medicinal cannabis for the prevention or management of nausea and vomiting in Australia
• Guidance for the use of medicinal cannabis in the treatment of chronic non-cancer pain in Australia

RACGP Position Statement

RACGP – Medicinal use of cannabis products

1 RACGP Position Statement: Medicinal use of cannabis products Much of the detail remains unclear. For example, the legislation does not specify which products will be covered under the amendment, and it does not specify which particular conditions or symptoms will be eligible for treatment with cannabis-based products. www.racgp.org.au

Cannabinoid Research

• Journal of cannabis and cannabinoid research  
  
• The Lambert Institute

Product selection

• The Compendium
• List of Manufacturers and suppliers of medicinal cannabis products
• The TGA’s list of products by active ingredient

Cannabis news, campaigns, organisations

• Cannabiz – 90-day free trial of the premium offering for ANZCCP members
• Drive Change
• Australian Medicinal Cannabis Association (AMCA)